位置:首页 > 产品库 > Brexpiprazole
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Brexpiprazole
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Brexpiprazole图片
CAS NO:913611-97-9
规格:≥98%
包装与价格:
包装价格(元)
25mg询价
50mg询价
100mg询价
250mg询价
500mg询价
1g询价
5g询价

Brexpiprazole (formerly OPC-34712; OPC34712; Rexulti) is a novel D2 dopamine partial agonist [also called serotonin-dopamine activity modulator (SDAM)] approved as an atypical antipsychotic drug. IT inhibits 5-HT2A receptor with a Ki value of 0.47 nMr. Although it failed Phase II clinical trials for ADHD, it has been designed to provide improved efficacy and tolerability (e.g., less akathisia, restlessness and/or insomnia) over established adjunctive treatments for major depressive disorder (MDD). Brexpiprazole was approved on 7/10/2015 for the treatment of schizophrenia, and as an adjunctive treatment for depression.

纯度:≥98%

CAS:913611-97-9

 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024